First jab of Sputnik V COVID-19 vaccine administered; to cost around Rs 1,000

HYDERABAD, TELANGANA INDIA, May 14, 2021 14:35 IST With the Sputnik V COVID-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories received the first jab of the vaccine in Hyderabad. The first consignment of imported doses of Sputnik V vaccine landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13. As per a statement, imported doses of the Sputnik V COVID-19 vaccine are presently priced at Rs 948 (+5 per cent GST) per dose, with the possibility of a lower price point when local supply begins. Further consignments of imported doses are expected over the upcoming months, the company said in a statement. Subsequently, the supply of the Sputnik V vaccine will start from Indian manufacturing partners. The company is working closely with its six manufacturing partners to fulfill regulatory requirements to ensure a smooth and timely supply. Dr Reddy's said it will work closely with stakeholders in the government and private sector to ensure the widest possible reach of the Sputnik V vaccine as part of the national inoculation effort. "With the rising cases in India, vaccination is our most effective tool in our battle against Covid-19. Contributing to the vaccination drive in India is our biggest priority right now to help Indians be healthy and safe," said G V Prasad, Co-Chairman and Managing Director.

पूर्ण विवरण

सम्बन्धित सामग्री

Russia's Sputnik V effectiveness against Omicron 75 percent: Vaccine developer

Moscow [Russia], January 19: The effectiveness of the Sputnik V COVID-19 vaccine against the Omicron coronavirus variant is 75 percent, Alexander Gintsburg, the head of Russia's Gamaleya Research Center, said on Tuesday. "In the population, the effectiveness of the Sputnik V vaccine in relation to Omicron ... is 75 percent," Gintsburg said in the Rossiya Segodnya press center. The Gamaleya head added that protection against Omicron increases to 100 percent if a person receives a Sputnik Light booster dose in six months but decreases to 56-57 percent if revaccination is not done. The Sputnik V effectiveness against Omicron decreases by eight times but it is still enough for protection, Gintsburg said, adding that the effectiveness of other vaccines decreases by 21 times.

Ratopati English पौष २०७८

Procurement process of Russian 'Sputnik V' COVID-19 vaccine in final stage

It has been confirmed that the Russian (Sputnik V) COVID-19 vaccine is to be procured from Russia with the effort of the private pharmaceutical company at the earliest.

The Rising Nepal जेष्ठ २०७८

'Nepal can manufacture COVID-19 vaccine if formulations, technology provided'

Lomus Pharmaceutical Pvt. Ltd. has got the authorization and manufacturing license to manufacture the Sputnik-V, a Russian vaccine. Similarly, Nepal is marking its way on producing the Remdesivir medicine. This is a good start for Nepal.

The Rising Nepal बैशाख २०७८

Nepal approves Russia's Sputnik V COVID-19 vaccine

Nepal gave conditional approval on Tuesday for the emergency use of the Russian Sputnik V COVID-19 vaccine, an official of the drug regulator said,

The Himalayan Times चैत्र २०७७

India reports 2,61,500 new COVID-19 cases, 1,501 deaths

India reported its highest-ever single-day spike of COVID-19 cases with over 2.61 lakh new cases and more than 1,500 deaths in the last 24 hours, according to the Union Health Ministry on Sunday. In the last 24 hours, 1,501 COVID-related deaths were reported in the country taking the death toll to 1,77,150. As many as 2,61,500 new COVID-19 cases have been reported in India in the last 24 hours. With this, the total number of cases has gone up to 1,47,88,109. The active number of cases in the country stands at 18,01,316. In the last 24 hours, 1,38,423 people recovered from the disease. With this, the total recoveries reached 1,28,09,643. According to the Indian Council of Medical Research, 15,66,394 samples were tested on Saturday. And, as many as 26,65,38,416 samples have been tested across the country till April 17. Meanwhile, the cumulative number of COVID-19 vaccine doses administered in the country stands at 12,26,22,590 till today. The Drug Controller General of India (DCGI) approved the use of the Russian Sputnik V vaccine against coronavirus in the country on April 12. Now, India has three vaccines Covishield, Covaxin and Sputnik V for its inoculation programme against COVID-19. From April 2, the government started vaccinating all people above 45 years. India started its vaccination drive on January 16 with priority given to all healthcare and frontline workers in the first phase. The second phase started on March 1 where doses were administered to people above the age of 60 and those between 45 and 59 years with specific comorbidities.

Ratopati English चैत्र २०७७

Russia ready to trial combined AstraZeneca, Sputnik V vaccine in Ukraine

MOSCOW, Jan 3: Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday.

Republica मंसिर २०७७

Russia's COVID-19 vaccine showed antibody response in initial trials

MOSCOW, Sept 5: Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.

Republica श्रावण २०७७